Drug Injuries
Gabapentin Dementia Lawsuit
Were you or a loved one diagnosed with Dementia or Cognitive Decline after long-term gabapentin use? The lawyers at Johnson//Becker, PLLC, are currently investigating cases on behalf of individuals diagnosed with cognitive decline and dementia after the long-term prescribed use of gabapentin or pregabalin. Learn more below.
Andexxa Lawsuit
Have you or a loved one experienced a thromboembolic event after taking Andexxa? The lawyers at Johnson//Becker, PLLC, are currently accepting new cases for injuries, complications or the unexpected passing of a patient that was caused by the use of Andexxa. Learn more below.
Dupixent Lawsuit: Cutaneous T-Cell Lymphoma (CTCL)
Have you been diagnosed with Cutaneous T-Cell Lymphoma (CTCL) after being prescribed Dupixent (dupilumab)? The lawyers at Johnson//Becker, PLLC, are currently accepting new cases for Dupixent induced lymphoma. Learn more below.
Zepbound Lawsuit
Recent reports from patients using the prescription drug Zepbound reveal patients suffering from long-term gastroparesis, ileus, or NAION. The lawyers at Johnson//Becker, PLLC are currently accepting new Zepbound lawsuits. Learn more below.
Trulicity Lawsuit
Johnson//Becker, PLLC lawyers are currently accepting new Trulicity stomach paralysis lawsuits. Learn more below.
Depo-Provera and Meningioma Brain Tumors Lawsuit
The lawyers at Johnson//Becker, PLLC, are investigating injuries associated with Pfizer’s Depo-Provera. Depo-Provera was approved by the Food & Drug Administration (FDA) in 1992 as an injectable form of birth control. Rather than daily pills, women who use Depo-Provera receive a shot every three months. It is estimated that over 74 million women globally rely on this medication.
Oxbryta Lawsuit
The U.S. Food and Drug Administration (FDA) announced on September 26, 2024, that Oxbryta (voxelotor) is being withdrawn from global markets.
Oxervate Lawsuit Investigation Ongoing for Johnson//Becker Lawyers
Oxervate, an eye drop used to treat neurotrophic keratitis (NK), has recently been associated with the development of plaques on the eye. These plaques, in some cases, can lead to corneal ulcers and potential blindness. Due to the recently reported effects associated with this drug, the lawyers at Johnson//Becker are investigating Oxervate (Cenegermin-bkbj ophthalmic solution).
Belbuca Lawsuit
Belbuca is an anti-opioid medication that has been associated with tooth decay and dental injuries. Learn more below.
Zubsolv Lawsuit
Zubsolv is an anti-opioid medication that has been associated with severe teeth injuries. Learn more below.